Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03938324 · ClinicalTrials.gov registry record · NA
Peer i-Coaching for Activated Self-Management Optimization in Adolescents and Young Adults With Chronic Conditions
A NA study of Sickle Cell Disease and Cystic Fibrosis, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 222
- Enrollment target
- 1
- Study location
NCT03938324: Completed NA study of Sickle Cell Disease and Cystic Fibrosis, sponsored by Duke University.
NCT03938324 is a NA study of Sickle Cell Disease and Cystic Fibrosis that has completed, run by Duke University. The registered enrollment target is 222 participants, below the 292-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target (24% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03938324, a NA study of Sickle Cell Disease and Cystic Fibrosis, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 222 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to test the efficacy of a peer support coaching intervention to improve activated chronic illness self-management versus an attention control group in 225 adolescents and young adults with childhood onset chronic conditions.
Primary Outcome
Self-management variable measured using the Partners in Health Scale (PIH): measures chronic illness self-management by assessing chronic condition self-management knowledge, partnership in treatment, recognition and management of symptoms, and coping. This 12 item self-report scale is scored on a 9-point Likert scale. The primary outcome is the overall score, which is the mean of the 12 items (possible range of 0 to 8, higher overall scores indicating better self-management).
Conditions Studied
Interventions
- BEHAVIORAL PiCASO Intervention Group
- BEHAVIORAL Sham Comparator: Attention Control Group
Study Locations (1)
North Carolina
- Duke University - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 222 participants |
| Start Date | 2019-10-29 |
| Est. Completion | 2024-06-19 |
| Phase | NA |
What the finished NCT03938324 record still lists
NCT03938324 is an interventional study that assigns participants to a tested intervention. The registered 222 participants enrollment target is mid-sized for trials with a published cap, below the 292-participant average among 213 other Sickle Cell Disease trials with a reported enrollment target (24% lower).
The record links to 9 conditions, with Sickle Cell Disease appearing as the primary indexed condition, and to 2 interventions - of which PiCASO Intervention Group is the first listed.
NCT03938324 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT03938324 about?
NCT03938324 is a clinical study titled "Peer i-Coaching for Activated Self-Management Optimization in Adolescents and Young Adults With Chronic Conditions". The purpose of this study is to test the efficacy of a peer support coaching intervention to improve activated chronic illness self-management versus an attention control group in 225 adolescents and young adults with childhood onset chronic conditions.
What is the current status of trial NCT03938324?
This trial is currently completed. It is a NA study. The enrollment target is 222 participants. The study started on 2019-10-29. Estimated completion is 2024-06-19.
What conditions does trial NCT03938324 study?
This clinical trial studies the following conditions: Sickle Cell Disease, Cystic Fibrosis, Diabetes Mellitus, Type 1, Systemic Lupus Erythematosus, Chronic Kidney Diseases.
What interventions are being tested in trial NCT03938324?
The interventions under investigation include: PiCASO Intervention Group (BEHAVIORAL), Sham Comparator: Attention Control Group (BEHAVIORAL).
Who is sponsoring clinical trial NCT03938324?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03938324 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sickle Cell Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03938324's enrollment target sits among peer trials
222 33rd of 213 higher than 181 of 213 other Sickle Cell Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sickle Cell Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Life Exposures Among Children With Sickle Cell Disease
RECRUITING · NA
-
Exercise in Child Health
RECRUITING · NA
-
Sickle Cell Children's Exercise Study (SuCCESs)
RECRUITING · NA
-
Cutaneous Hydration Assessment in SCD
RECRUITING · NA
-
MULTIsite Feasibility of MUSIc Therapy to Address Quality Of Life in Sickle Cell Disease
RECRUITING · NA
-
Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04939610 · 222 participants · Phase 1
A Study of 177Lu-FAP-2286 in Advanced Solid Tumors
- NCT05424783 · 222 participants
MRI And GPS Informing Choices for Prostate Cancer Treatment (MAGIC)
- NCT05568264 · 222 participants · NA
Effects of a Physical Therapy Intervention on Motor Delay in Infants Admitted to a Neonatal Intensive Care Unit
- NCT05605574 · 222 participants · NA
Longitudinal Early Advance Care Planning Discussions and Documentation (LEADD) Program: An Exploratory Study in Adolescents and Young Adults (AYAs) Receiving Hematopoietic Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI